# Precision Medicine
Latest news and articles about Precision Medicine
Total: 7 articles found
Tiny Claws, Massive Force: Chinese Researchers Unveil Fiber-Integrated 3D Micro-Tweezers
Chinese scientists have developed a groundbreaking 3D fiber-integrated micro-tweezer that is 100,000 times more powerful than traditional models. Published in Nature, the technology allows for high-precision, programmable manipulation of microscopic objects, potentially revolutionizing nanomedicine and micro-manufacturing.
The Silicon Apothecary: China’s AI Push to Standardize Traditional Medicine
China is leveraging artificial intelligence to modernize its multi-billion dollar Traditional Chinese Medicine industry by digitizing the sensory expertise of master herbalists. The National Modern TCM Innovation Center’s new AI tools aim to standardize quality and shift the sector toward a 'precision medicine' model.
Shanghai’s Post-2025 Blueprint: Betting on the Brain-Computer Interface Frontier
Shanghai has released its 15th Five-Year Plan for the service industry, placing heavy emphasis on Brain-Computer Interfaces, precision medicine, and AI-driven healthcare. The blueprint aims to transform the city into a global leader for clinical innovation and high-tech medical services between 2026 and 2030.
Illumina’s Genomic Gambit: Standardizing the Search for Cancer’s Ghost Cells
Illumina has launched its first commercial whole-genome sequencing kit for Minimal Residual Disease (MRD) research, aiming to standardize high-sensitivity cancer monitoring. The solution supports both solid and liquid tumors, marking a significant shift from targeted gene panels to comprehensive genomic surveillance in clinical research.
Chasing the Holy Grail: HEC Pharm’s Triple Threat at AACR 2026 Signals China’s Oncology Pivot
HEC Pharm presented three innovative oncology candidates at the 2026 AACR meeting, showcasing breakthroughs in Pan-RAS molecular glues, bispecific antibodies, and oral PD-L1 inhibitors. This move highlights the company's strategic pivot toward high-complexity R&D and its ambition to compete in the global precision medicine market.
Salubris Biotherapeutics Unveils Promising Clinical Data for Novel ADC, Signaling China’s Global Precision Oncology Push
Salubris Biotherapeutics has reported positive Phase 1/2 clinical data for its 5T4-targeting ADC, JK06, at the AACR 2026 conference. The drug shows promising safety and efficacy in treating advanced lung and breast cancers, marking a key advancement in the company's international clinical pipeline.
Precision Oncology Gains Ground in China: AmoyDx Secures Regulatory Nod for c-Met Lung Cancer Diagnostic
Amoy Diagnostics has received NMPA approval for its c-Met gene amplification kit, a companion diagnostic for the lung cancer drug Savolitinib. This development marks a vital step in China's push for localized precision oncology and sophisticated personalized medicine tools.